An Open-label, Single-dose, Randomized-to-sequence, 4-period Crossover Bioavailability Study of Bazedoxifene Contained in Bazedoxifene/Conjugated Estrogen Tablets Administered to Healthy Postmenopausal Women
Phase of Trial: Phase I
Latest Information Update: 07 May 2015
At a glance
- Drugs Conjugated estrogens/bazedoxifene (Primary) ; Bazedoxifene
- Indications Atrophic vaginitis; Postmenopausal osteoporosis; Vasomotor symptoms
- Focus Pharmacokinetics
- Sponsors Wyeth
- 07 Dec 2006 The expected completion date for this trial is now 31 Aug 2006.
- 18 Nov 2006 New trial record.